Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.060
-0.120 (-2.87%)
At close: May 12, 2025, 4:00 PM
4.050
-0.010 (-0.25%)
After-hours: May 12, 2025, 6:31 PM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $31.24 million as of May 12, 2025. Its market cap has increased by 136.85% in one year.
Market Cap
31.24M
Enterprise Value
7.25M
1-Year Change
136.85%
Ranking
Category
Stock Price
$4.06
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $31.24M, a decrease of -57.11%. That is a compound annual growth rate of -21.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 31.45M | -3.46% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |